Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 May-Jun;6(3):825-831.
doi: 10.1016/j.jaip.2017.10.011. Epub 2017 Nov 10.

Dietary Fatty Acid Modification for the Treatment of Aspirin-Exacerbated Respiratory Disease: A Prospective Pilot Trial

Thomas R Schneider  1 , Christina B Johns  1 , Marina L Palumbo  1 , Katherine C Murphy  1 , Katherine N Cahill  2 , Tanya M Laidlaw  3
Affiliations
Clinical Trial

Dietary Fatty Acid Modification for the Treatment of Aspirin-Exacerbated Respiratory Disease: A Prospective Pilot Trial

Thomas R Schneider et al. J Allergy Clin Immunol Pract. 2018 May-Jun.

Abstract

Background: The high levels of eicosanoid production and the clinical efficacy of leukotriene-modifying pharmacotherapies for patients with aspirin-exacerbated respiratory disease (AERD) suggest that other interventions targeting arachidonic acid dysregulation may also improve disease control.

Objective: To assess the utility of a high omega-3/low omega-6 diet for the treatment of AERD.

Methods: Prospective, nonblinded dietary intervention in 10 adult patients with AERD at Brigham and Women's Hospital in Boston, MA. The primary objective was for subjects to reduce dietary omega-6 fatty acid consumption to less than 4 g/d and increase omega-3 intake to more than 3 g/d. The primary outcome was change in urinary leukotriene E4, with changes in other eicosanoids, platelet activation, lung function, and patient-reported questionnaires also assessed.

Results: Of the 10 subjects who screened for the study, all 10 completed the dietary intervention. Urinary leukotriene E4 decreased by 0.17 ng/mg (95% CI, -0.29 to -0.04; P = .02) and tetranor prostaglandin D-M decreased by 0.66 ng/mg creatinine (95% CI, -1.21 to -0.11; P = .02). There was a 15.1-point reduction in the 22-item Sino-Nasal Outcome Test score (95% CI, -24.3 to -6.0; P = .01), a 0.27-point reduction in the 7-item Asthma Control Questionnaire score (95% CI, -0.52 to -0.03; P = .03), and no change in FEV1 % predicted (P = .92) or forced vital capacity % predicted (P = .74). All patients lost some weight over the 2-week intervention period, and there were no diet-associated adverse events.

Conclusions: A high omega-3/low omega-6 diet may be an appropriate adjunct treatment option for patients with AERD.

Keywords: AERD; Aspirin; Aspirin-exacerbated respiratory disease; Asthma; Diet; Fatty acids; LTE(4); NSAIDs; Nasal polyps; Omega-3; Omega-6; Samter's Triad.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Omega-3 and omega-6 FA intake during two-week dietary intervention
Change in average daily nutritional intake of omega-6 (TOP) and omega-3 (BOTTOM) fatty acids are shown. Individual data points are shown with means for each phase.
Figure 2
Figure 2. Urinary LTE4 and PGD-M levels during two-week dietary intervention
Change in uLTE4 (TOP) and uPGD-M (BOTTOM) levels are shown. Individual data points are shown with means for each phase.
Figure 3
Figure 3. SNOT-22 and ACQ scores during two-week dietary intervention
Change in patient-reported Sino-Nasal Outcome Test-22 (TOP) and Asthma Control Questionnaire (BOTTOM) scores are shown. Individual data points are shown with means for each phase.
See this image and copyright information in PMC

Comment in

References

    1. Laidlaw TM, Boyce JA. Aspirin-Exacerbated Respiratory Disease–New Prime Suspects. The New England journal of medicine. 2016;374(5):484–488. - PubMed
    1. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr. 2001;131(7):1918–1927. - PubMed
    1. Kelley DS, Taylor PC, Nelson GJ, Mackey BE. Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men. Lipids. 1998;33(2):125–130. - PubMed
    1. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J, Spur BW, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. The New England journal of medicine. 1985;312(19):1217–1224. - PubMed
    1. von Schacky C, Kiefl R, Jendraschak E, Kaminski WE. n-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo. J Lab Clin Med. 1993;121(2):302–309. - PubMed

Publication types

LinkOut - more resources